Subscribe
Share
Share
Embed
Maria Alice Willrich, Ph.D., discusses kappa free light chain testing, Mayo Clinic Laboratories’ innovative new approach to evaluating for multiple sclerosis. The automated assay detects and measures immunoglobulin kappa free light chains in cerebrospinal fluid. Faster, less expensive, and more sensitive than traditional oligoclonal banding analysis, kappa free light chain testing is a significant quality improvement over manual testing that yields objective, qualitative test results.
A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.